FDA Inspection
Rafarm S.A.Rafarm S.A. – FDA Inspection, May 19, 2023
Record Details
This FDA Inspection record concerns Rafarm S.A., with an inspection on May 19, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · b8f780cb-150f-479c-972b-49798ad3c1d3
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1225663
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Rafarm S.A.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 21, 2024 | VAI | Drug Quality Assurance | |
| June 4, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 11, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 30, 2019 | Not classified | Office of Inspections and Investigations | |
| May 31, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Rafarm S.A.
- FDA Inspection 1300434 - 2024-06-21
- FDA Inspection 1155967 - 2021-06-04
- FDA Inspection 1123693 - 2020-03-11
- FDA Inspection 1101881 - 2019-07-30
- FDA Inspection 1111463 - 2018-05-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.